942 related articles for article (PubMed ID: 11745948)
1. Expression and localization of protein inhibitor of neuronal nitric oxide synthase in Duchenne muscular dystrophy.
Guo Y; Petrof BJ; Hussain SN
Muscle Nerve; 2001 Nov; 24(11):1468-75. PubMed ID: 11745948
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy.
Brenman JE; Chao DS; Xia H; Aldape K; Bredt DS
Cell; 1995 Sep; 82(5):743-52. PubMed ID: 7545544
[TBL] [Abstract][Full Text] [Related]
3. Mini- and full-length dystrophin gene transfer induces the recovery of nitric oxide synthase at the sarcolemma of mdx4cv skeletal muscle fibers.
Decrouy A; Renaud JM; Lunde JA; Dickson G; Jasmin BJ
Gene Ther; 1998 Jan; 5(1):59-64. PubMed ID: 9536265
[TBL] [Abstract][Full Text] [Related]
4. Muscular dystrophy in mdx mice despite lack of neuronal nitric oxide synthase.
Chao DS; Silvagno F; Bredt DS
J Neurochem; 1998 Aug; 71(2):784-9. PubMed ID: 9681470
[TBL] [Abstract][Full Text] [Related]
5. Sparing of mdx extraocular muscles from dystrophic pathology is not attributable to normalized concentration or distribution of neuronal nitric oxide synthase.
Wehling M; Stull JT; McCabe TJ; Tidball JG
Neuromuscul Disord; 1998 Feb; 8(1):22-9. PubMed ID: 9565987
[TBL] [Abstract][Full Text] [Related]
6. Relocalization of neuronal nitric oxide synthase (nNOS) as a marker for complete restoration of the dystrophin associated protein complex in skeletal muscle.
Wells KE; Torelli S; Lu Q; Brown SC; Partridge T; Muntoni F; Wells DJ
Neuromuscul Disord; 2003 Jan; 13(1):21-31. PubMed ID: 12467729
[TBL] [Abstract][Full Text] [Related]
7. [Association between dystrophin and neuronal nitric oxide synthase in muscles of progressive muscular dystrophy].
Wang S; Shen D
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):155-7. PubMed ID: 11953148
[TBL] [Abstract][Full Text] [Related]
8. Loss of sarcolemma nNOS in sarcoglycan-deficient muscle.
Crosbie RH; Barresi R; Campbell KP
FASEB J; 2002 Nov; 16(13):1786-91. PubMed ID: 12409321
[TBL] [Abstract][Full Text] [Related]
9. Dual AAV therapy ameliorates exercise-induced muscle injury and functional ischemia in murine models of Duchenne muscular dystrophy.
Zhang Y; Yue Y; Li L; Hakim CH; Zhang K; Thomas GD; Duan D
Hum Mol Genet; 2013 Sep; 22(18):3720-9. PubMed ID: 23681067
[TBL] [Abstract][Full Text] [Related]
10. iNOS expression in dystrophinopathies can be reduced by somatic gene transfer of dystrophin or utrophin.
Louboutin JP; Rouger K; Tinsley JM; Halldorson J; Wilson JM
Mol Med; 2001 May; 7(5):355-64. PubMed ID: 11474581
[TBL] [Abstract][Full Text] [Related]
11. mdx muscle pathology is independent of nNOS perturbation.
Crosbie RH; Straub V; Yun HY; Lee JC; Rafael JA; Chamberlain JS; Dawson VL; Dawson TM; Campbell KP
Hum Mol Genet; 1998 May; 7(5):823-9. PubMed ID: 9536086
[TBL] [Abstract][Full Text] [Related]
12. Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy.
Bia BL; Cassidy PJ; Young ME; Rafael JA; Leighton B; Davies KE; Radda GK; Clarke K
J Mol Cell Cardiol; 1999 Oct; 31(10):1857-62. PubMed ID: 10525423
[TBL] [Abstract][Full Text] [Related]
13. Expression and regulation of protein inhibitor of neuronal nitric oxide synthase in ventilatory muscles.
Guo Y; Greenwood MT; Petrof BJ; Hussain SN
Am J Respir Cell Mol Biol; 1999 Feb; 20(2):319-26. PubMed ID: 9922224
[TBL] [Abstract][Full Text] [Related]
14. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins.
Tidball JG; Wehling-Henricks M
Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129
[TBL] [Abstract][Full Text] [Related]
15. Absence of neuronal nitric oxide synthase (nNOS) as a pathological marker for the diagnosis of Becker muscular dystrophy with rod domain deletions.
Torelli S; Brown SC; Jimenez-Mallebrera C; Feng L; Muntoni F; Sewry CA
Neuropathol Appl Neurobiol; 2004 Oct; 30(5):540-5. PubMed ID: 15488030
[TBL] [Abstract][Full Text] [Related]
16. Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy.
Chang WJ; Iannaccone ST; Lau KS; Masters BS; McCabe TJ; McMillan K; Padre RC; Spencer MJ; Tidball JG; Stull JT
Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9142-7. PubMed ID: 8799168
[TBL] [Abstract][Full Text] [Related]
17. Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy.
Lai Y; Thomas GD; Yue Y; Yang HT; Li D; Long C; Judge L; Bostick B; Chamberlain JS; Terjung RL; Duan D
J Clin Invest; 2009 Mar; 119(3):624-35. PubMed ID: 19229108
[TBL] [Abstract][Full Text] [Related]
18. Constitutive properties, not molecular adaptations, mediate extraocular muscle sparing in dystrophic mdx mice.
Porter JD; Merriam AP; Khanna S; Andrade FH; Richmonds CR; Leahy P; Cheng G; Karathanasis P; Zhou X; Kusner LL; Adams ME; Willem M; Mayer U; Kaminski HJ
FASEB J; 2003 May; 17(8):893-5. PubMed ID: 12670877
[TBL] [Abstract][Full Text] [Related]
19. Attempting to Compensate for Reduced Neuronal Nitric Oxide Synthase Protein with Nitrate Supplementation Cannot Overcome Metabolic Dysfunction but Rather Has Detrimental Effects in Dystrophin-Deficient mdx Muscle.
Timpani CA; Trewin AJ; Stojanovska V; Robinson A; Goodman CA; Nurgali K; Betik AC; Stepto N; Hayes A; McConell GK; Rybalka E
Neurotherapeutics; 2017 Apr; 14(2):429-446. PubMed ID: 27921261
[TBL] [Abstract][Full Text] [Related]
20. Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin.
Li D; Bareja A; Judge L; Yue Y; Lai Y; Fairclough R; Davies KE; Chamberlain JS; Duan D
J Cell Sci; 2010 Jun; 123(Pt 12):2008-13. PubMed ID: 20483958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
